357 related articles for article (PubMed ID: 29348470)
1. Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat.
Li H; Wu G; Fang Q; Zhang M; Hui X; Sheng B; Wu L; Bao Y; Li P; Xu A; Jia W
Nat Commun; 2018 Jan; 9(1):272. PubMed ID: 29348470
[TBL] [Abstract][Full Text] [Related]
2. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance.
Hale C; Chen MM; Stanislaus S; Chinookoswong N; Hager T; Wang M; Véniant MM; Xu J
Endocrinology; 2012 Jan; 153(1):69-80. PubMed ID: 22067317
[TBL] [Abstract][Full Text] [Related]
3. Elevated Fibroblast growth factor 21 (FGF21) in obese, insulin resistant states is normalised by the synthetic retinoid Fenretinide in mice.
Morrice N; Mcilroy GD; Tammireddy SR; Reekie J; Shearer KD; Doherty MK; Delibegović M; Whitfield PD; Mody N
Sci Rep; 2017 Mar; 7():43782. PubMed ID: 28256636
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor 21 improves insulin resistance and ameliorates renal injury in db/db mice.
Kim HW; Lee JE; Cha JJ; Hyun YY; Kim JE; Lee MH; Song HK; Nam DH; Han JY; Han SY; Han KH; Kang YS; Cha DR
Endocrinology; 2013 Sep; 154(9):3366-76. PubMed ID: 23825123
[TBL] [Abstract][Full Text] [Related]
6. Fgf21 impairs adipocyte insulin sensitivity in mice fed a low-carbohydrate, high-fat ketogenic diet.
Murata Y; Nishio K; Mochiyama T; Konishi M; Shimada M; Ohta H; Itoh N
PLoS One; 2013; 8(7):e69330. PubMed ID: 23874946
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice.
Lin Z; Tian H; Lam KS; Lin S; Hoo RC; Konishi M; Itoh N; Wang Y; Bornstein SR; Xu A; Li X
Cell Metab; 2013 May; 17(5):779-89. PubMed ID: 23663741
[TBL] [Abstract][Full Text] [Related]
8. FGF21 gene therapy as treatment for obesity and insulin resistance.
Jimenez V; Jambrina C; Casana E; Sacristan V; Muñoz S; Darriba S; Rodó J; Mallol C; Garcia M; León X; Marcó S; Ribera A; Elias I; Casellas A; Grass I; Elias G; Ferré T; Motas S; Franckhauser S; Mulero F; Navarro M; Haurigot V; Ruberte J; Bosch F
EMBO Mol Med; 2018 Aug; 10(8):. PubMed ID: 29987000
[TBL] [Abstract][Full Text] [Related]
9. Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity.
Mraz M; Bartlova M; Lacinova Z; Michalsky D; Kasalicky M; Haluzikova D; Matoulek M; Dostalova I; Humenanska V; Haluzik M
Clin Endocrinol (Oxf); 2009 Sep; 71(3):369-75. PubMed ID: 19702724
[TBL] [Abstract][Full Text] [Related]
10. Central Resistin/TLR4 Impairs Adiponectin Signaling, Contributing to Insulin and FGF21 Resistance.
Benomar Y; Amine H; Crépin D; Al Rifai S; Riffault L; Gertler A; Taouis M
Diabetes; 2016 Apr; 65(4):913-26. PubMed ID: 26740596
[TBL] [Abstract][Full Text] [Related]
11. Hepatic insulin resistance and increased hepatic glucose production in mice lacking Fgf21.
Camporez JP; Asrih M; Zhang D; Kahn M; Samuel VT; Jurczak MJ; Jornayvaz FR
J Endocrinol; 2015 Sep; 226(3):207-17. PubMed ID: 26203166
[TBL] [Abstract][Full Text] [Related]
12. FGF21 Regulates Metabolism Through Adipose-Dependent and -Independent Mechanisms.
BonDurant LD; Ameka M; Naber MC; Markan KR; Idiga SO; Acevedo MR; Walsh SA; Ornitz DM; Potthoff MJ
Cell Metab; 2017 Apr; 25(4):935-944.e4. PubMed ID: 28380381
[TBL] [Abstract][Full Text] [Related]
13. Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21.
Assini JM; Mulvihill EE; Burke AC; Sutherland BG; Telford DE; Chhoker SS; Sawyez CG; Drangova M; Adams AC; Kharitonenkov A; Pin CL; Huff MW
Endocrinology; 2015 Jun; 156(6):2087-102. PubMed ID: 25774553
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor 21 reverses suppression of adiponectin expression via inhibiting endoplasmic reticulum stress in adipose tissue of obese mice.
Guo Q; Xu L; Liu J; Li H; Sun H; Wu S; Zhou B
Exp Biol Med (Maywood); 2017 Feb; 242(4):441-447. PubMed ID: 27811171
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory effects of exercise training in adipose tissue do not require FGF21.
Porter JW; Rowles JL; Fletcher JA; Zidon TM; Winn NC; McCabe LT; Park YM; Perfield JW; Thyfault JP; Rector RS; Padilla J; Vieira-Potter VJ
J Endocrinol; 2017 Nov; 235(2):97-109. PubMed ID: 28765264
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor 21 improves hepatic insulin sensitivity by inhibiting mammalian target of rapamycin complex 1 in mice.
Gong Q; Hu Z; Zhang F; Cui A; Chen X; Jiang H; Gao J; Chen X; Han Y; Liang Q; Ye D; Shi L; Chin YE; Wang Y; Xiao H; Guo F; Liu Y; Zang M; Xu A; Li Y
Hepatology; 2016 Aug; 64(2):425-38. PubMed ID: 26926384
[TBL] [Abstract][Full Text] [Related]
17. An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice.
Holland WL; Adams AC; Brozinick JT; Bui HH; Miyauchi Y; Kusminski CM; Bauer SM; Wade M; Singhal E; Cheng CC; Volk K; Kuo MS; Gordillo R; Kharitonenkov A; Scherer PE
Cell Metab; 2013 May; 17(5):790-7. PubMed ID: 23663742
[TBL] [Abstract][Full Text] [Related]
18. The suppression of hepatic glucose production improves metabolism and insulin sensitivity in subcutaneous adipose tissue in mice.
Casteras S; Abdul-Wahed A; Soty M; Vulin F; Guillou H; Campana M; Le Stunff H; Pirola L; Rajas F; Mithieux G; Gautier-Stein A
Diabetologia; 2016 Dec; 59(12):2645-2653. PubMed ID: 27631137
[TBL] [Abstract][Full Text] [Related]
19. Association between insulin resistance and impairment of FGF21 signal transduction in skeletal muscles.
Jeon JY; Choi SE; Ha ES; Kim TH; Jung JG; Han SJ; Kim HJ; Kim DJ; Kang Y; Lee KW
Endocrine; 2016 Jul; 53(1):97-106. PubMed ID: 26758997
[TBL] [Abstract][Full Text] [Related]
20. Nutritional regulation of fibroblast growth factor 21: from macronutrients to bioactive dietary compounds.
Pérez-Martí A; Sandoval V; Marrero PF; Haro D; Relat J
Horm Mol Biol Clin Investig; 2016 Sep; 30(1):. PubMed ID: 27583468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
